December 18, 2019 08:13 AM ESTUpdated 10:12 AM

Psychedelic research gains momentum, as early trial suggests micro-dosing LSD is safe

Natalie Grover

Reporter

Psychedelics have been long neglected as the subject of vigorous scientific research after governments branded them as illegal hedonistic compounds with no therapeutic potential. But …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Psychedelic research gains momentum, as early trial suggests micro-dosing LSD is safe

Natalie Grover

Reporter

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer

RFK Jr. defends HHS staff cuts, reorganization plans in House, Senate hearings

RFK Jr. says his opinions of vaccines are ‘irrelevant.’ Former FDA chief Califf disagrees

AbbVie doubles down on siRNA with $335M upfront bet on ADARx

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B

Psy­che­del­ic re­search gains mo­men­tum, as ear­ly tri­al sug­gests mi­cro-dos­ing LSD is safe

Reporter

Sign up to read this article for free.

more like this

Celldex Therapeutics

Hampton, NJ, USA

Psychedelic research gains momentum, as early trial suggests micro-dosing LSD is safe